6 trends tracked about this subject — the full history, oldest to newest below.
Eli Lilly's market value surges as Kailera's weight-loss pill faces market setbacks despite successful clinical efficacy in China.
The FDA is launching a pilot program to accelerate the review process for new pharmaceutical manufacturing facilities, starting with Eli Lilly and Regeneron.
Eli Lilly shares have hit a new all-time high following European regulatory progress and expanded access to GLP-1 treatments.
Eli Lilly's Jaypirca has received a positive CHMP recommendation for the treatment of chronic lymphocytic leukemia (CLL) in the European Union.
Sangamo Therapeutics' bankruptcy filing and asset sale to Lilly and Astellas is making waves in the biotech industry.
Speculation swirls around a 79-year-old patient who received an experimental weight loss drug, with former President Trump as the suspected recipient.